Mark Stahl
About Mark Stahl
Mark Stahl serves as the Executive Director of Clinical Development at Insmed Incorporated, a position he has held since 2024. He has an extensive educational background with degrees in Medicine (MD) and Cell/Cellular and Molecular Biology (PhD) from Albert Einstein College of Medicine, and he has held various roles in clinical development and academia over the years.
Work at Insmed
Mark Stahl serves as the Executive Director of Clinical Development at Insmed Incorporated. He has held this position since 2024, contributing to the company's clinical initiatives in the San Diego Metropolitan Area. His role involves overseeing clinical development strategies and ensuring the effective execution of clinical trials.
Education and Expertise
Mark Stahl holds a Doctor of Medicine (MD) degree from Albert Einstein College of Medicine, where he studied medicine from 1998 to 2008. He also earned a Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from the same institution during the same period. Additionally, he obtained a Bachelor of Arts (B.A.) in Biology/Biological Sciences from The Johns Hopkins University from 1993 to 1997.
Professional Background
Mark Stahl's professional background includes various roles in clinical development and academia. He completed an internship in Internal Medicine at UC San Diego Health System from 2008 to 2009. He served as a Physician Scientist at UCLA Health from 2009 to 2014. He then worked as an Assistant Professor at Penn State Milton S. Hershey Medical Center from 2014 to 2018. Following this, he held the position of Director of Clinical Development at Neurocrine Biosciences from 2018 to 2021, and later served as Senior Director of Clinical Development at Avidity Biosciences, Inc. from 2021 to 2024.
Career Timeline
Mark Stahl's career timeline reflects a progression through various significant roles in the medical and clinical development fields. After completing his education, he began his internship at UC San Diego Health System in 2008. He transitioned to UCLA Health as a Physician Scientist, followed by a position at Penn State Milton S. Hershey Medical Center as an Assistant Professor. He then moved to Neurocrine Biosciences as Director of Clinical Development, and subsequently to Avidity Biosciences as Senior Director before joining Insmed in 2024.